Aura Biosciences (AURA) Operating Expenses (2020 - 2026)

Aura Biosciences' Operating Expenses history runs 7 years deep, the most recent figure standing at $34.9 million for Q1 2026.

• Quarterly Operating Expenses rose 20.08% year-over-year to $34.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $118.6 million (up 15.35% YoY) and the FY2025 annual result came in at $112.8 million, up 17.35% from the prior year.
• Operating Expenses was $34.9 million for Q1 2026 at Aura Biosciences, up from $27.2 million in the prior quarter.
• Across five years, Operating Expenses topped out at $34.9 million in Q1 2026 and bottomed at $12.8 million in Q1 2022.
• A 5-year average of $22.9 million and a median of $22.8 million in 2024 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses soared 174.88% — and 2025, when it decreased 2.05%.
• Aura Biosciences' Operating Expenses stood at $17.6 million in 2022, then soared by 40.71% to $24.8 million in 2023, then increased by 12.2% to $27.8 million in 2024, then declined by 2.05% to $27.2 million in 2025, then rose by 28.01% to $34.9 million in 2026.
• Business Quant data shows AURA's Operating Expenses at $34.9 million in Q1 2026, $27.2 million in Q4 2025, and $27.9 million in Q3 2025.